MedTrace Logo

GEKO Venous Thromboembolism Prevention Study

NCT05476913 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1200

Last updated 2025-03-04

No results posted yet for this study

Summary

This multicentre, randomised geko™ venous thromboembolism (VTE) prevention study will prospectively collect clinical data on VTE occurrences in immobile patients after stroke, who will be randomised, on a 1:1 allocation, to receive either standard of care (Intermittent Pneumatic Compression) or geko™ neuromuscular electrostimulation device. The aim is to assess the prevention of VTE during a follow-up period of 90 days (three months) post-randomisation.

Conditions

Interventions

DEVICE

geko™ device

Neuromuscular electrical stimulation of the peroneal nerve

Sponsors & Collaborators

  • National Institute for Health Research, United Kingdom

    collaborator OTHER_GOV

  • Keele University

    collaborator OTHER

  • University Hospitals of North Midlands NHS Trust

    collaborator OTHER

  • University of California

    collaborator OTHER

  • Bournemouth University

    collaborator OTHER

  • Firstkind Ltd

    lead INDUSTRY

Principal Investigators

  • Christine Roffe, MD FRCP FESO · Keele University, University Hospitals of North Midlands NHS Trust

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-06
Primary Completion
2025-04-30
Completion
2025-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05476913 on ClinicalTrials.gov